- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02716844
Effect Of Exercises On Kinesiophobia, And Other Symptoms Related to Osteoporosis
The Effect Of The Clinical Pilates Exercises On Kinesiophobia, And Other Symptoms Related to Osteoporosis
Aim: Investigating the effects of Clinical Pilates Exercise on kinesiophobia, pain, functional status and quality of life of the patients diagnosed with osteoporosis.
Method: 47 patients were assessed and randomly divided into 2 groups. Exercise group patients joined exercise program regularly that was held 3 times a week, 1 hour a day, during 6 weeks with physiotherapist. Control group patients continued their normal daily lives without any exercise. After 7 patients quit the study for various reasons, 40 women with primary osteoporosis (control group n=20, exercise group n= 20), completed the study and were assessed at the beginning and at the end of 6 weeks. As assesment' measurements Tampa Kinesiophobia Scale (TKS), Visual Analog Scale (VAS), Short Form McGill (SF-McGill), Pain Disability Index (PDI), Oswestry Disability Index (ODI), Berg Balance Test (BBT), Timed Up- Go Test (TUG), Chair Sit-Stand Test (CSST), Chair Sit and Reach Test (CSRT), Back Scratch Test (BST), Quality of life Questionnaire European Foundation for Osteoporosis (QUALEFFO-41), Hospital Anxiety and Depression Scale (HADS), Satisfaction with Life Scale (SLS) and Health Assesment Questionnaire (HAQ) were performed.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Woman diagnosed with osteoporosis between the ages 50-75 within the last year
Exclusion Criteria
- History of fractures
- Joint replacements or fixation of the joints at the lower extremities or the spine
- Any neurological or muscle diseases
- Inability to continuously attend the exercise program
- Any secondary diseases resulting in decreased mobility or functional status
- Visual, hearing or mental problems that could prevent communication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Exercise Group,
Clinical Pilates exercise were given for 6 weeks, 3 days in a week
|
Clinical Pilates exercise were given for 6 weeks, 3 days in a week
|
NO_INTERVENTION: Control Group
Nothing given to control group, told to continue their normal life for 6 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the level of fear and avoidance associated with movement assessed using the Tampa Kinesiophobia Scale at 6 weeks
Time Frame: At the beginning and at the end of 6 weeks
|
40 osteoporosis patients filled Tampa Kinesiophobia Scale at the beginning and at the end of 6 weeks in order to measure the level of fear and avoidance associated with movement.
If an individual receives a high score, according to the scale, this result indicates a high level of kinesiophobia .
It has not a specific unit.
There is not an adverse events in this test.
|
At the beginning and at the end of 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the level of pain intensity in the morning assessed using Visual Analogue Scale (VAS) at 6 weeks.
Time Frame: At the beginning and at the end of 6 weeks
|
VAS is an horizontal line, 100 mm in length, anchored by word descriptors at each end.
The patient marks on the line the point that they feel represents their perception of their current pain intensity.
The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks and recorded in centiemeters (cm).
|
At the beginning and at the end of 6 weeks
|
Change in the level of pain intensity during activity assessed using Visual Analogue Scale (VAS) at 6 weeks.
Time Frame: At the beginning and at the end of 6 weeks
|
VAS is an horizontal line, 100 mm in length, anchored by word descriptors at each end.
The patient marks on the line the point that they feel represents their perception of their current pain intensity.
The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks and recorded in centiemeters (cm).
|
At the beginning and at the end of 6 weeks
|
Change in the level of pain intensity at rest assessed using Visual Analogue Scale (VAS) at 6 weeks.
Time Frame: At the beginning and at the end of 6 weeks
|
VAS is an horizontal line, 100 mm in length, anchored by word descriptors at each end.
The patient marks on the line the point that they feel represents their perception of their current pain intensity.
The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks and recorded in centiemeters (cm).
|
At the beginning and at the end of 6 weeks
|
Change in the level of experienced pain assessed with using Short Form - McGill Pain Questionnaire (SF-McGill)
Time Frame: At the beginning and at the end of 6 weeks
|
Short Form - McGill Pain Questionnaire (SF-McGill) provides a multidimensional evaluation of the experienced pain.
Patients' pain descriptions (SF-McGill S), experienced pain level during study (Sf-McGill VAS) and total pain intensity measured via a 6-point Likert- Type Scale (SF-McGill L) was recorded.
|
At the beginning and at the end of 6 weeks
|
Change in the level of influence of patients' general pain intensity on their daily life activities and functionality assessed using Pain Disability Index (PDI).
Time Frame: At the beginning and at the end of 6 weeks
|
Pain Disability Index (PDI) (score out of 70) is a questionnaire filled by the patients.
|
At the beginning and at the end of 6 weeks
|
Change in the level of influence of patients' low back pain intensity on their daily life activities and functionality assessed using Oswestry Low Back Pain Disability Scale (ODI)
Time Frame: At the beginning and at the end of 6 weeks
|
Oswestry Low Back Pain Disability Scale (ODI)(score out of 70) is a questionnaire filled by the patients .
|
At the beginning and at the end of 6 weeks
|
Change in the level of functional balance assessed using Berg Balance Test (BBT).
Time Frame: At the beginning and at the end of 6 weeks
|
Berg Balance Test (BBT)(score out of 56) evaluates postural control mechanism and dynamic and static balance while doing functional activities in adult population.
This test was assessed by the physiotherapist.
|
At the beginning and at the end of 6 weeks
|
Change in the level of functional balance assessed using The Timed Up and Go Test (TUG).
Time Frame: At the beginning and at the end of 6 weeks
|
The Timed Up and Go Test (TUG) assesses the functional balance and mobility of subjects.
Patients stands up upon therapist's command walks 3 meters, turns around, walks back to the chair and sits down.
The performance is repeated by the patience 3 times and the shortest performance time is recorded in seconds (sec).
|
At the beginning and at the end of 6 weeks
|
Change in the level of lower extremity proximal muscle's strength and endurance assessed using Chair Sit and Stand Test (CSST) at 6 weeks.
Time Frame: At the beginning and at the end of 6 weeks
|
In Chair Sit and Stand Test (CSST), number of sitting-standing repetitions in 30 sec.
was recorded by the physiotherapist.
|
At the beginning and at the end of 6 weeks
|
Change in the level of functional flexibility of lower extremity assessed using Chair Sit and Stand Test (CSST) at 6 weeks.
Time Frame: At the beginning and at the end of 6 weeks
|
assesses the functional flexibility of the lower extremity in adult (23).
Participant sits on the edge of a chair.
One foot must remain flat on the floor.
The other leg is extended forward with the knee straight, heel on the floor, and ankle bent at 90°.
Patients place one hand on top of the other with tips of the middle fingers even.
Patients keep the knee straight, and hold the reach for 2 seconds.
If the fingertips touch the toes then the score is zero (0).
If they do not touch, measure the distance between the fingers and the toes (a negative score/-), if they overlap, measure by how much (a positive score/+) and recorded in cm.
|
At the beginning and at the end of 6 weeks
|
Change in the level of functional flexibility of upper extremity assessed using Back Scratch Test (BST) at 6 weeks.
Time Frame: At the beginning and at the end of 6 weeks
|
Back Scratch Test (BST)(cm) evaluates the functional flexibility of the patient's upper extremity.
Patients are asked to rotate their shoulder externally with palms facing their back.
Their hand fingers extend while trying to reach the lowest point, the other arm internally rotates while trying to reach the highest point.
Patients are asked their fingertips to be closer to each other.
If finger tips do not touch each other, the distance between them is recorded in cm assumed as a negative score, if the fingertips touch each other, then the score is assumed as zero.
If they overlap, it is recorded in cm taking as positive score.
Three repetitions are performed consecutively and the best score was recorded.
|
At the beginning and at the end of 6 weeks
|
Change in the level of quality of life assessed using Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) at 6 weeks
Time Frame: At the beginning and at the end of 6 weeks
|
A. Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) examine the five dimensions of health such as pain, physical functioning, social activities, general health assessment and mental function of patients with osteoporosis.
Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) was filled by the patients and score was calculated as percentage (%).
|
At the beginning and at the end of 6 weeks
|
Change in the level of anxiety and depression assessed using Hospital Anxiety And Depression Scale (HADS) at 6 weeks
Time Frame: At the beginning and at the end of 6 weeks
|
This scale was filled by the patients.
It has no special units.
The elevation of the total score indicates the increased anxiety and depression levels (score out of 42).
|
At the beginning and at the end of 6 weeks
|
Change in the level of chronic functional impairment assessed using Health Assessment Questionnaire (HAQ) at 6 weeks
Time Frame: At the beginning and at the end of 6 weeks
|
Health Assessment Questionnaire (HAQ) (score out of 24) is commonly used for evaluating the patients' chronic functional impairment caused by rheumatic diseases.
This questionnaire was filled by the patients and it has no special units.
|
At the beginning and at the end of 6 weeks
|
Change in the level of life satisfaction assessed using Satisfaction with Life Scale (SLS) at 6 weeks
Time Frame: At the beginning and at the end of 6 weeks
|
This scale (score out of 35) was filled by the patients.
It has no special units.
|
At the beginning and at the end of 6 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUT11/16,B:30.2.HAC.0.20.05.04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Age Related Osteoporosis | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of VertebraeUnited States, Poland, Italy
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States, Puerto Rico
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruitingPost Menopausal OsteoporosisFrance
-
AmgenCompletedPost Menopausal OsteoporosisFrance
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisSpain, South Africa, Germany, Mexico, United States, Canada, France, United Kingdom, Italy, Belgium, Australia, Poland, Denmark, Hungary, Czech Republic, Norway
-
Hoffmann-La RocheGlaxoSmithKlineCompletedPost Menopausal OsteoporosisFrance
-
Novartis PharmaceuticalsCompletedPost-menopausal OsteoporosisColombia, Belgium, Sweden, Hong Kong, United States, Hungary, Switzerland, Australia, Germany, Italy, Canada, Poland, Argentina, Thailand, Norway, New Zealand, France, Finland
Clinical Trials on Exercise
-
University of Kansas Medical CenterRecruiting
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of
-
University of AlbertaWomen and Children's Health Research Institute, CanadaRecruitingType 1 Diabetes | Post-menopauseCanada
-
Uskudar UniversityCompleted
-
Yuksek Ihtisas UniversityCompletedDementia | Frailty | Cognitive Function | Reaction Time | Aerobic Exercise | Balance ExerciseTurkey
-
National Taiwan Normal UniversityCompletedAging | Cognitive DeclineTaiwan
-
Wayne State UniversityUnknown